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Purpose: To determine if clinical evaluation of parapapillary atrophy (PPA) significantly 
improves the ability to distinguish open-angle glaucoma (OAG) patients from glaucoma 
suspects.
Methods: Patients in this study were under evaluation for glaucoma and had open angles, 
at least one reliable 24-2 SITA-standard automatic perimetry, and digital stereophotographs 
of the optic disc. PPA was identified clinically as a parapapillary region of absent (βPPA) or 
hyper/hypopigmented (αPPA) retinal pigment epithelium. A single masked observer evaluated 
photos for: vertical cup-to-disc ratio (CDR), clock hours of total and βPPA, βPPA as percentage 
width of the optic disc, presence or absence of βPPA at each disc quadrant, and ordinal rating of 
total PPA. Generalized linear models were used to determine odds of an abnormal or borderline 
glaucoma hemifield test (GHT) as a function of PPA variables and covariates; model fit was 
assessed using the log-likelihood ratio test.
Results: Of 410 consecutive patients, 540 eyes (of 294 patients) met inclusion criteria. Mean age 
was greater among patients with abnormal compared with normal GHT (P , 0.001), but sex and 
race/ethnicity did not differ between groups (P $ 0.22). Age, central corneal thickness (CCT) 
and CDR (P # 0.006), but not intraocular pressure (IOP) (P = 0.71), were significant univariable 
predictors of the odds of an abnormal GHT. All PPA parameters significantly   predicted GHT 
(P # 0.03), except presence of temporal βPPA (P = 0.25). Adjustment for age, CCT, IOP, and 
CDR reduced the association between PPA and GHT, and model fit was not greatly improved 
by addition of PPA variables.
Conclusions: Addition of most PPA parameters to a model already containing commonly 
assessed variables including age, CCT, IOP, and CDR does not significantly improve the ability 
to distinguish OAG patients from glaucoma suspects.
Keywords: glaucoma, visual fields, parapapillary atrophy, optic nerve
Introduction
Glaucomatous optic neuropathy may be evaluated by direct or indirect ophthalmoscopy 
of the optic nerve, optic nerve photography, or computerized imaging technologies. 
Clinical features of glaucomatous optic neuropathy include atrophy of the retinal 
nerve fiber layer, focal or diffuse narrowing of the neuroretinal rim, optic disc splinter 
hemorrhage (DH) and parapapillary atrophy (PPA).1–3
PPA is a form of outer retinal atrophy that abuts the optic disc and can be divided 
into alpha (α) and beta (β) zones.4–6 Because this atrophy most often lies adjacent to 
but does not completely surround the nerve, the term parapapillary may be preferable 
to peripapillary atrophy, though they are used interchangeably in the literature. In βPPA 
the sclera and large choroidal vessels are visible, as the retinal pigment epithelium Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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(RPE) and most of the photoreceptors are absent.4,5 In αPPA, 
there is an irregular arrangement of RPE cells that can result 
clinically in both hypo- and hyperpigmentation. The α zone 
is more peripheral than the β zone when both are present.
Of note, there are no imaging devices to provide 
automated assessment of DH or PPA, which at the pres-
ent time are assessed either by patient examination or by 
photographic interpretation. Interestingly, several studies 
addressing the topic have found that PPA and DH tend to 
occur together in eyes and, additionally, tend to occur in 
the same regions of the eye, leading to the possibility that 
PPA may be useful as an indicator of increased likelihood of 
prior, present, or future disc hemorrhage.7–12 Because βPPA 
is present in 15%–20% of normal eyes, its presence is less 
specific for glaucoma than DH, which occurs only in 0.6% 
of healthy eyes.11,13 Given that DH is transient, lasting weeks 
to months, and that PPA is stable and progressive, it may 
be advantageous to rely on PPA parameters for glaucoma 
diagnosis and monitoring.8,12
αPPA and βPPA have been evaluated in glaucoma using 
quantitative analysis of optic nerve photographs   (morphometry) 
typically by manually outlining and measuring the area of PPA 
using a slide projector, imaging processing software, or with 
confocal scanning laser ophthalmoscopy.5–7,14–20 Both αPPA 
and βPPA are larger and occur more frequently in eyes with 
glaucoma than in normal eyes, though βPPA is more specific 
for glaucoma.5,6,14,15 Using these morphometric techniques, 
PPA has been reported to be helpful in differentiating between 
normal and glaucomatous eyes.5,6,14,15,21–24
While many morphometric investigations of PPA in 
glaucomatous and normal eyes have reported significant 
differences between these 2 groups, there is a paucity of 
information on how clinical evaluation of PPA may guide 
the clinician in the diagnosis of open-angle glaucoma 
(OAG). Additionally, it is difficult clinically to estimate 
quantitative PPA parameters, such as area of PPA, due to 
its heterogenous shape. Despite this, in a clinical assess-
ment using direct   ophthalmoscopy alone, information 
including the PPA circumferential extent and amount of 
neuroretinal rim narrowing increased the sensitivity and 
specificity for detection of glaucomatous visual field loss.1 
However, some previous evaluations of PPA did not consider 
potential confounding variables such as age or intraocular 
pressure (IOP) that are typically available to the clinician at 
the time of diagnosis.1,5,6,14 In order to determine the clini-
cal utility of PPA evaluation in glaucoma assessment, we 
developed a clinical PPA grading system and conducted 
this   investigation to determine if clinical PPA assessment 
could improve the prediction of glaucomatous visual field 
loss beyond that of standard clinical variables such as age, 
central corneal   thickness (CCT), IOP and vertical   cup-to-disc 
ratio (CDR).
Patients and methods
This retrospective cross-sectional study was approved by the 
Institutional Review Board at Weill Cornell Medical College 
and New York Presbyterian Hospital. Patients under 18 years 
of age or with a history of corneal disease or keratorefrac-
tive surgery were excluded, as were patients with visually 
significant cataract (visual acuity ,20/40), inflammatory 
eye disease, ocular trauma and non-glaucomatous optic 
neuropathy, or visual field loss.
Included patients were under evaluation for glaucoma and 
had documented open angles on examination. All patients 
had at least one reliable (fixation loss ,33%; false-positive 
rate ,33%; false-negative rate ,33%) and repeatable 24-2 
SITA-standard automatic perimetry with the Humphrey Field 
Analyzer II (Carl Zeiss Meditec, Dublin, CA, USA). Patients 
were classified as having OAG if the glaucoma hemifield test 
(GHT) was borderline or outside normal limits; patients were 
classified as glaucoma suspects if the GHT was within normal 
limits. All patients had also undergone optic nerve digital 
stereophotography of acceptable or excellent quality with 
a Topcon TRC 50EX Retinal Camera (Topcon Co., Tokyo, 
Japan) within 18 months of inclusion. Demographic and 
clinical data including age, sex, self-reported race/  ethnicity, 
CCT, and IOP on the day of examination were obtained by 
chart review.
One reviewer (NMR) evaluated optic nerve stereopho-
tographs in a masked fashion using stereoscopic viewing 
lenses (Figure 1). CDR was recorded. PPA was identified 
clinically as a parapapillary region of absent (βPPA) or 
hyper/hypopigmented (αPPA) retinal pigment epithelium. 
The circumferential extent of total (both α and β) PPA and 
βPPA were recorded in clock hours; the maximal radial 
βPPA extent (width) was estimated as a percentage of maxi-
mal optic disc dimensions (regardless of absolute optic disc 
size); the presence or absence of βPPA was assessed at each 
optic nerve head quadrant; and an ordinal rating (0–3) of 
total PPA was assigned as follows: grade 0 represented no 
clinically identifiable αPPA or βPPA; grade 1 represented 
any level of αPPA only; grade 2 represented any level of 
αPPA with mild and moderate βPPA; and grade 3 repre-
sented βPPA that was extensive either in circumference 
(12 clock hours) or volume (larger in area than the optic 
disc itself).Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Statistical analyses were performed using Stata 11/IC 
(StataCorp LP, College Station, TX, USA).   Differences 
in characteristics between patients with normal and 
abnormal/borderline GHT were assessed using two-sample 
t-tests or the chi-squared test. Differences in quantity of PPA 
between groups were assessed using generalized estimating 
equations to control for the inter-eye correlation of individu-
als; differences in geographic distribution of PPA were tested 
with the chi-squared test; and the Kruskal–Wallis test was 
used to test for differences in ordinal PPA rating. Generalized 
linear models with robust standard errors adjusted for cluster-
ing by patient were fit with a logit link function. Odds ratios 
(ORs) of an abnormal/borderline GHT were estimated as a 
function of increasing PPA and covariates. The likelihood-
ratio test was used to calculate the statistical improvement 
in model fit when PPA parameters were added to models 
already containing age, CCT, IOP, and CDR. All statistical 
tests were 2-sided with a 0.05 level of significance.
Results
Patient characteristics, including PPA parameters, are pre-
sented in Table 1. Patients with OAG were significantly older 
than glaucoma suspects (61.9 versus 55.3 years; P , 0.001), 
and there was no difference in sex or ethnic/racial distribu-
tion between groups (P $ 0.22). Patients with OAG had 
significantly greater PPA than glaucoma suspects for all 
PPA variables measured (P # 0.02) except for presence of 
temporal PPA (P = 0.25).
Univariable logistic models were fit to predict the change 
in odds of OAG as a function of increasing age, CCT, IOP, 
and CDR (Table 2). Increasing age (OR = 1.4 per 10 years, 
95% confidence interval (CI) 1.2, 1.6, P , 0.001) and CDR 
(OR = 1.3 per 0.1 units, 95% CI 1.2, 1.4, P , 0.001) but not 
IOP (P = 0.71) were significantly associated with greater 
odds of OAG. Likewise, increasing CCT was significantly 
associated with decreased odds of an OAG (OR = 0.9 per 
10 µm, 95% CI 0.9, 1.0, P , 0.001).
Univariable logistic models were also fit to determine 
the association of PPA variables with OAG (Table 3A). 
Again, an increase in each of the PPA parameters (P # 0.03), 
except for presence of temporal βPPA (P = 0.30), was found 
to be significantly associated with an increase in the odds 
of OAG.
Each PPA variable was then added to a logistic model 
already containing age, CCT, IOP, and CDR, and the odds 
of OAG as a function of increasing PPA was determined 
when adjusting for covariates (Table 3B). With adjustment 
for age, CCT, IOP, and CDR, the magnitude of association 
between nasal βPPA and OAG increased compared with 
the crude association and trended toward statistical signifi-
cance (OR = 1.6, 95% CI 1.0, 2.7, P = 0.06). However, after 
adjustment for clinical covariates no other PPA variables 
were statistically significant predictors of the odds of OAG 
(P $ 0.10).
Finally, the likelihood-ratio test was used to calculate the 
change in statistical fit of the model containing age, CCT, 
Figure 1 Clinical parapapillary atrophy (PPA) evaluation of 2 patients. A) Total PPA clock hours, 12; βPPA clock hours, 5; βPPA as percentage of disc, 60%; βPPA present, temporal; 
ordinal rating of total PPA, 3. B) Total PPA clock hours, 8; βPPA clock hours, 4; βPPA as percentage of disc, 20%; βPPA present, temporal; ordinal rating of total PPA, 2.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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and the percentage of eyes correctly classified increased by 
1.2% to a total of 64.4%.
Discussion
Past investigations have demonstrated a strong association 
between PPA and glaucoma.5–7,14–17,25–28 The purpose of the 
current investigation was to determine if the clinician could 
utilize this association in the evaluation of glaucoma patients 
using visual inspection only. In this investigation, using our 
clinical grading scale, we replicated trends in the spatial 
and quantitative distribution of PPA that have been reported 
among patients with and without glaucoma.6,14,15,29 While 
PPA variables were, on their own, significantly predictive 
of the odds of OAG, this association was greatly attenuated 
by adjustment for 4 variables that comprise part of a typical 
glaucoma evaluation: age, CCT, IOP, and CDR. Further-
more, when values for these covariates were already known, 
modeling of the odds of OAG was not greatly improved by 
the consideration of PPA variables. This suggests that in 
clinically evaluating and diagnosing glaucoma there may 
be little incremental value to assessing PPA.
In the current study, patients with OAG had greater 
PPA that glaucoma suspects for every measure of PPA that 
was considered (though the difference was not statistically 
significant for βPPA of the temporal quadrant). Past   studies 
have shown that βPPA tends to be larger in areas where 
the neuroretinal rim is focally narrow.14 Also, as measured 
with planimetry, the spatial distribution of PPA differs in 
glaucoma, with PPA being present nasally in 5%–9% of 
normal patients and 21%–38% of glaucoma patients.6,14,15 
A similar trend was confirmed between patients with OAG 
and glaucoma suspects in the current study. However, the 
existence of nasal βPPA among 34.7% of OAG patients 
and only 18.3% of suspects indicates that nasal βPPA is 
not a sensitive predictor of disease. Past investigations 
have also demonstrated that PPA is most commonly 
located temporally, followed by inferotemporally and then 
superotemporally.29 In the present study, βPPA was most 
commonly located temporally among both OAG patients 
and glaucoma suspects.
In a study by Jonas and colleagues, the investigators 
sought to determine which features of the optic disc best 
distinguished normal and glaucomatous patients.20 The 
authors found that size of α and β zone PPA, assessed using 
planimetric techniques, were among the least useful optic 
disc characteristics for differentiating normal subjects from 
subjects with either preperimetric or perimetric glaucoma. 
The variables that consistently offered the greatest diagnostic 
Table 1 Patient and parapapillary atrophy characteristics
Glaucoma 
suspects
OAG P-value
number eyes (patients) 229 (157) 311 (209) –
Age (years) 55.3 (±5.2) 61.9 (±14.2) ,0.001
Female (%) 64.1 66.0 0.76
Race/ethnicity (%)
Caucasian 34.6 26.3 0.22
African-American 20.5 30.6
hispanic 29.5 32.1
Other race/ethnicity 15.4 11.0
Clock hours total PPA 5.1 (±3.5) 6.7 (±3.7) ,0.001
Clock hours βPPA 3.7 (±3.5) 5.2 (±4.3) ,0.001
Percent width βPPA 15.1 (±22.0) 21.0 (±28.2) 0.02
Percent eyes with βPPA 
at disc quadrant:
Temporal (%) 44.5 49.5 0.25
inferior (%) 24.9 34.4 0.02
nasal (%) 18.3 34.7 ,0.001
superior (%) 13.5 24.1 0.002
Percent eyes with PPA 
ordinal rating:
0 (%) 7.4 5.5 ,0.001
1 (%) 54.2 38.1
2 (%) 31.9 39.4
3 (%) 6.6 17.1
Abbreviations: OAg, open-angle glaucoma; PPA, parapapillary atrophy.
Table 2 simple logistic models: odds of open-angle glaucoma as 
a function of common clinical variables
OR (95% CI) P-value
Age (per 10 years) 1.4 (1.2, 1.6) ,0.001
CCT (per 10 µm)  0.9 (0.9, 1.0) 0.006
iOPa (per 1 mm hg) 1.0 (1.0, 1.0) 0.71
CDR (per 0.1 units) 1.3 (1.2, 1.4) ,0.001
aIOP values were with treatment in 59% of patients classified as OAG.
Abbreviations: CCT, central corneal thickness; iOP, intraocular pressure; CDR, 
vertical cup-to-disc ratio.
IOP, CDR, and a single PPA variable compared with the 
same model without a PPA variable (Table 3B). Inclusion 
of the nasal βPPA variable significantly improved model fit 
(X2[1] = 4.5, P = 0.03). Other PPA variables did not have a 
statistically significant impact on the fit of the logistic model 
(P $ 0.06). While the results of the likelihood-ratio test for 
total PPA clock hours (X2[1] = 3.6, P = 0.06) and ordinal 
rating of PPA (X2[3] = 6.8, P = 0.08) trended toward statis-
tical significance, these variables were not significant inde-
pendent predictors of OAG in their respective multivariable 
models. The logistic model containing age, CCT, IOP, and 
CDR correctly predicted the OAG status of 63.2% of eyes. 
Inclusion of total PPA clock hours in this model improved 
prediction of OAG status more than other PPA variables, Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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power in the study by Jonas et al were: CDR, neuroretinal 
rim area, rim-to-disc area and cup-to-disc area.20 While these 
findings largely agree with results from the current study, 
the current study did not morphometrically   investigate optic 
disc parameters as was done by Jonas et al. Our   investigation 
more specifically addressed the incremental importance of 
PPA variables, since in nearly all instances the clinician 
will have knowledge of a patient’s age, CCT, IOP, and 
some measurement of CDR. Like Jonas and colleagues, we 
determined that PPA variables are not the most important 
clinical variables for distinguishing glaucomatous and non-
glaucomatous patients.
The present study also has the advantage of utilizing 
a multivariable technique that allows for outcomes to be 
modeled as a function of multiple variables, as often occurs 
in the clinical setting. In this study, we considered a model 
that contained four standard clinical glaucoma variables 
(age, CCT, IOP, and CDR) with and without the addition 
of PPA variables. The addition of most PPA variables to 
this model resulted in little incremental improvement in the 
modeling of our data. This suggests that the more parsimoni-
ous model – the model without PPA – more appropriately 
represents these data.
A growing literature suggests that PPA may be more 
useful for evaluating progression than for detecting 
glaucoma.16–18,25 Studies have shown that PPA increases in 
size as glaucoma progresses and that it is not specific to the 
mechanism of glaucoma.16–18,22,25 In one report of eyes with 
progressive cupping, the area of PPA enlarged in 64%, as 
opposed to 17% of eyes with glaucoma that did not have 
progressive cupping.16 Teng and colleagues showed that 
over a period of 3 years, glaucomatous eyes with β zone PPA 
were more likely to show evidence of visual field progression 
and that a greater area of βPPA was predictive of more rapid 
progression. As in the   present study, Teng et al found that 
CCT was significantly associated with PPA. However, the 
association between visual field progression and presence 
of βPPA persisted in a multivariable model controlling for 
baseline demographic and ocular characeristics.25 Likewise, 
Jonas et al found that the area of βPPA was significantly 
larger among patients with progressive disease and that 
progression was associated with age, and the area of βPPA 
and the neuroretinal rim.17,18 However, in a study of ocular 
hypertensives Quigley and colleagues did not find a signifi-
cant difference in the prevalence of PPA between patients 
with and without progressive glaucoma.30
The current investigation was retrospective in nature so 
its results cannot be extrapolated to determine risk or future 
odds of glaucoma. It is possible that patients with normal 
visual fields (glaucoma suspects) considered in the study 
might have had pre-perimetric glaucoma, and some of the 
glaucoma suspects considered might have been referred for 
evaluation in part based upon the presence of PPA. However, 
both of the above limitations are commonly encountered in 
clinical glaucoma management and may actually add to the 
relevance of this work. This study is less quantitative than 
past studies that have used planimetric measurement of PPA. 
However, the clinical grading system that was developed for 
this study was designed to more closely resemble the sort 
of evaluation routinely performed in a clinical glaucoma 
examination. Notwithstanding, by assessing the additional 
benefit conferred by inclusion of PPA evaluation as part of 
Table 3 simple and multiple logistic models: odds of open-angle glaucoma as a function of parapapillary atrophy (PPA) variables
A. Simple logistic models B. Adjusted models and model fit
Crude 
OR (95% CI)
P-value Adjusted 
ORa (95% CI)
P-value Likelihood-ratio 
test P-value (X2)
Clock hours total PPA 
(per 3 hours)
1.4 (1.2, 1.7) ,0.001 1.2 (1.0, 1.4) 0.10 0.06 (3.6)
Clock hours βPPA 
(per 3 hours)
1.4 (1.2, 1.6) ,0.001 1.1 (0.9, 1.3) 0.20 0.16 (2.0)
nasal βPPA 1.4 (1.5, 3.7) ,0.001 1.6 (1.0, 2.7) 0.06 0.03 (4.5)
inferior βPPA 1.6 (1.0, 2.4) 0.03 1.1 (0.7, 1.7) 0.70 0.65 (0.2)
Temporal βPPA 1.2 (0.8, 1.8) 0.30 0.9 (0.6, 1.3) 0.60 0.49 (0.5)
superior βPPA 2.0 (1.2, 3.4) 0.006 1.2 (0.7, 2.1) 0.50 0.51 (0.5)
Ordinal rating total PPA 
(reference: rating = 0)
1 1.0 (0.4, 2.1) 0.90 0.8 (0.4, 1.7) 0.50 0.08 (6.8)
2 1.7 (0.7, 3.8) 0.20 1.1 (0.5, 2.6) 0.70
3 3.5 (1.4, 9.1) 0.009 1.6 (0.6, 4.6) 0.30
aAdjusted for: age, CCT, iOP, and CDR.Clinical Ophthalmology
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a standard glaucoma exam, this investigation contributes 
to the understanding of the association between PPA   
and OAG.
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